AI Portfolio Summary
In 2025 Q4, Privium Fund Management B.V. maintained a portfolio of 65 distinct positions. The most significant new addition to the portfolio was VIRIDIAN THERAPEUTIC, which now represents 0.99% of the total fund value. They heavily accumulated shares in LEMONADE INC, increasing their position by 71.2%. Conversely, Privium Fund Management B.V. completely exited their position in ABIVAX SA.
Total Positions
65
Quarter
2025 Q4
Top Holding
TSLA (18.9%)
Top 10 Concentration
68.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 65
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSLA
TESLA INC
|
Consumer Cyclical | 18.92% | 19.51% |
#1
Prev: #1
|
7.6 | -15,500 | -6.4% |
P
S
|
228,500 | $102,761,020 |
$226.63
+93.3%
|
2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
SHOP
SHOPIFY INC
|
Technology | 12.15% | 11.09% |
#2
1
Prev: #3
|
4.9 | -5,000 | -1.2% |
P
S
|
410,000 | $65,997,700 |
$39.40
+299.0%
|
2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
SPOT
SPOTIFY TECHNOL...
|
Communication Services | 7.27% | 11.92% |
#3
1
Prev: #2
|
3.0 | -27,000 | -28.4% |
P
S
|
68,000 | $39,488,280 |
$180.42
+218.7%
|
2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
PLTR
PALANTIR TECHNO...
|
Technology | 6.55% | 6.56% |
#4
Prev: #4
|
2.6 | no change | no change |
P
S
|
200,000 | $35,550,000 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMZN
AMAZON COM INC
|
Consumer Cyclical | 5.14% | 5.88% |
#5
Prev: #5
|
2.1 | -28,000 | -18.8% |
P
S
|
121,000 | $27,929,220 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 4.87% | 2.94% |
#6
3
Prev: #9
|
2.0 | -75,747 | -16.0% |
P
S
|
398,204 | $26,436,764 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 3.51% | 2.93% |
#7
3
Prev: #10
|
1.4 | -8,070 | -3.2% |
P
S
|
240,824 | $19,051,587 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COIN
COINBASE GLOBAL...
|
Financial Services | 3.29% | 4.79% |
#8
1
Prev: #7
|
1.3 | no change | no change |
P
S
|
79,000 | $17,865,060 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LMND
LEMONADE INC
|
Financial Services | 3.25% | 1.40% |
#9
6
Prev: #15
|
3.5 | 103,259 | 71.2% |
P
S
|
248,259 | $17,671,076 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SE
SEA LTD
|
Consumer Cyclical | 3.24% | 5.14% |
#10
4
Prev: #6
|
1.3 | -22,000 | -13.8% |
P
S
|
138,000 | $17,604,660 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVDA
NVIDIA CORPORAT...
|
Technology | 2.78% | 2.72% |
#11
Prev: #11
|
1.1 | no change | no change |
P
S
|
81,000 | $15,106,500 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Healthcare | 2.38% | 1.31% |
#12
4
Prev: #16
|
3.1 | 21,555 | 41.5% |
P
S
|
73,480 | $12,931,745 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMD
ADVANCED MICRO ...
|
Technology | 2.37% | 1.75% |
#13
Prev: #13
|
0.9 | no change | no change |
P
S
|
60,000 | $12,849,600 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRQR
PROQR THRAPEUTI...
|
Healthcare | 1.99% | 1.91% |
#14
2
Prev: #12
|
2.8 | 359,475 | 7.2% |
P
S
|
5,357,762 | $10,822,680 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IREN
IREN LIMITED
|
Financial Services | 1.95% | 1.10% |
#15
3
Prev: #18
|
3.1 | 150,000 | 115.4% |
P
S
|
280,000 | $10,575,600 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASTS
AST SPACEMOBILE...
|
Technology | 1.94% | 0.97% |
#16
5
Prev: #21
|
2.9 | 35,000 | 31.8% |
P
S
|
145,000 | $10,531,350 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.91% | 1.15% |
#17
Prev: #17
|
2.8 | 4,146 | 7.9% |
P
S
|
56,878 | $10,388,198 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 1.83% | 4.05% |
#18
10
Prev: #8
|
2.8 | 30,270 | 7.8% |
P
S
|
416,270 | $9,961,342 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 1.64% | 1.04% |
#19
Prev: #19
|
0.7 | no change | no change |
P
S
|
305,972 | $8,885,427 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.51% | 1.57% |
#20
6
Prev: #14
|
2.7 | 67,698 | 23.4% |
P
S
|
357,502 | $8,222,546 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.99% | — |
#21
Prev: #—
|
2.4 | 173,516 | no change |
NEW
|
173,516 | $5,399,818 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 0.93% | 0.71% |
#22
1
Prev: #23
|
2.4 | 18,000 | 9.2% |
P
S
|
214,622 | $5,026,447 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.78% | 0.58% |
#23
1
Prev: #24
|
2.4 | 1,055 | 12.7% |
P
S
|
9,355 | $4,241,183 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRK
MERCK & CO INC
|
Healthcare | 0.71% | 0.97% |
#24
4
Prev: #20
|
0.4 | -27,800 | -43.2% |
P
S
|
36,593 | $3,851,779 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.60% | 0.22% |
#25
14
Prev: #39
|
2.3 | 23,010 | 13.5% |
P
S
|
193,010 | $3,281,170 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #26) |
0.3 | -30,412 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 0.00% | 0.42% |
Sold All 😨
(Was: #27) |
0.3 | -53,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 0.00% | 0.35% |
Sold All 😨
(Was: #31) |
0.3 | -126,923 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.00% | 0.27% |
Sold All 😨
(Was: #34) |
0.3 | -70,400 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALXO
ALX ONCOLOGY HL...
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #43) |
0.3 | -509,059 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PAAS
PAN AMERN SILVE...
|
Basic Materials | 0.00% | 0.13% |
Sold All 😨
(Was: #46) |
0.3 | -18,531 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RXRX
RECURSION PHARM...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #49) |
0.3 | -119,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SBSW
SIBANYE STILLWA...
|
Basic Materials | 0.00% | 0.05% |
Sold All 😨
(Was: #57) |
0.3 | -26,232 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 65 holdings